Overview

Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
This is a phase IV, open-label and single-arm study of patients with non-malignant pain due to osteoarthritis, rheumatoid arthritis, low back pain and joint/muscle pain, who were not responding to non-opioid analgesics. The primary objective was to assess the efficacy of buprenorphine transdermal patch for pain control among these patients.
Phase:
Phase 4
Details
Lead Sponsor:
Mundipharma Pharmaceuticals Sdn. Bhd.
Treatments:
Buprenorphine